Merck KGaA is a science and technology company, which engages in the manufacture of pharmaceutical and chemical products. It operates through the following sectors: Healthcare, Life Science, Performance Materials and Corporate and Other. The Healthcare sector discovers, develops, and produces prescription medicines used to treat cancer, multiple sclerosis, and infertility. The Life Science sector provides scientists with laboratory materials, technologies, and services. The Performance Materials sector offers specialty chemicals and materials for demanding applications. The firm offers pharma and biopharma manufacturing, pharmaceutical research, pharma quality control, and government and academic research services. The company was founded by Friedrich Jacob Merck in 1668 and is headquartered in Darmstadt, Germany. MKKGY is listed on the Pink Current market tier. OTC market data is provided by OTC Markets Group, Inc (otcmarkets.com).

The Versum acquisition has increased Merck's exposure to the attractive semiconductor materials business just as those products are becoming more important to an increasingly complex and shrinking manufacturing process.

Minority shareholders only own about 30% of Merck, which give them limited influence over the strategic direction of the organization.

Although it still possesses high market share and strong margins, Merck's liquid crystal business appears likely to continue declining primarily on new Chinese entrants and market shifts to other display standards, such as OLED. 

Merck's legacy healthcare products, such as Rebif and Erbitux, are under pressure from indirect competition, which creates a significant hurdle for its biopharmaceutical pipeline to offset. 

Merck's strategy to use partnerships to increase productivity and share costs in its healthcare pipeline could boost returns in that segment.

Merck's life sciences segment should continue to benefit from expanding pharmaceutical pipelines as a key supplier to those firms' R&D and manufacturing operations.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Full disclosure

Merck

Why Robinhood?

About MKKGY

Merck KGaA is a science and technology company, which engages in the manufacture of pharmaceutical and chemical products. It operates through the following sectors: Healthcare, Life Science, Performance Materials and Corporate and Other.

MKKGY Key Statistics

Analyst ratings

59%

Merck

Why Robinhood?

Merck KGaA is a science and technology company, which engages in the manufacture of pharmaceutical and chemical products. It operates through the following sectors: Healthcare, Life Science, Performance Materials and Corporate and Other. Show more

MKKGY Key Statistics

Analyst ratings

59%

Merck KGaA is a science and technology company, which engages in the manufacture of pharmaceutical and chemical products. It operates through the following sectors: Healthcare, Life Science, Performance Materials and Corporate and Other.